Home › Funds › STEMPOINT CAPITAL LP › OVID
STEMPOINT CAPITAL LP position in OVID
OVID THERAPEUTICS INC · Health Care
STEMPOINT CAPITAL LP reported holding 2,417,283 shares of OVID (OVID THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$6.5M, representing 1.44% of its reported portfolio and ranking #24 among its reported holdings. STEMPOINT CAPITAL LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How STEMPOINT CAPITAL LP's OVID position evolved
STEMPOINT CAPITAL LP first disclosed a stake in OVID in Q2 2026 at 2,417,283 shares (US$6.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 2.42M | $6.50M | New |
About OVID and 13F data
OVID (OVID THERAPEUTICS INC) is a Health Care company. 52 other funds we track also report a position in OVID — the largest reported positions include Affinity Asset Advisors, LLC (US$27.3M), ADAR1 Capital Management, LLC (US$20.0M), SILVERARC CAPITAL MANAGEMENT, LLC (US$8.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OVID
- Affinity Asset Advisors, LLC 10.14M sh · $27.29M · Q2 2026
- ADAR1 Capital Management, LLC 7.42M sh · $19.95M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 3.10M sh · $8.34M · Q2 2026
- Ikarian Capital, LLC 2.27M sh · $6.11M · Q2 2026
- Propel Bio Management, LLC 1.12M sh · $3.00M · Q2 2026
- Rosalind Advisors, Inc. 1.11M sh · $2.98M · Q2 2026
- Sio Capital Management, LLC 1.01M sh · $2.70M · Q2 2026
- Saturn V Capital Management LP 663.06K sh · $1.78M · Q2 2026
- Ally Bridge Group (NY) LLC 624.56K sh · $1.68M · Q2 2026
More on STEMPOINT CAPITAL LP
FAQ
How long has STEMPOINT CAPITAL LP held OVID?
STEMPOINT CAPITAL LP has disclosed OVID holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is STEMPOINT CAPITAL LP's current position in OVID?
As of Q2 2026, STEMPOINT CAPITAL LP holds 2.42M shares of OVID (OVID THERAPEUTICS INC), valued at $6.50M, representing 1.44% of its reported portfolio and ranking #24.
Has STEMPOINT CAPITAL LP been buying or selling OVID?
In the latest 13F filing (Q2 2026), STEMPOINT CAPITAL LP newly opened its position in OVID.
Which other funds hold OVID?
Other major institutional holders of OVID include Affinity Asset Advisors, LLC, ADAR1 Capital Management, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.